Stock ALIM ALIMERA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Real-time Estimate Cboe BZX
Other stock markets
 20:16:16 10/05/2024 BST 		5-day change 1st Jan Change
3.495 USD +3.40% Intraday chart for Alimera Sciences, Inc. -5.21% -19.91%
03-25 Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target MT
03-19 Alimera Sciences, Inc. Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target
MT
Alliance Global Partners Upgrades Alimera Sciences to Buy From Neutral, Adjusts Price Target to $8 From $4.50
MT
HC Wainwright Adjusts Price Target on Alimera Sciences to $5 From $9, Keeps Buy Rating
MT
Alliance Global Partners Downgrades Alimera Sciences to Neutral Rating From Buy, Adjusts Price Target to $4.50 From $11
MT
HC Wainwright Adjusts Price Target on Alimera Sciences to $9 From $8, Reiterates Buy Rating
MT
HC Wainwright Adjusts Alimera Sciences' Price Target to $8 from $10, Keeps Buy Rating
MT
HC Wainwright Adjusts Alimera Sciences Price Target to $10 From $12, Maintains Buy Rating
MT
ALIMERA SCIENCES : Alliance Global Partners Adjusts Alimera Sciences PT to $14.50 From $16.50, Maintains Buy Rating
MT
ALIMERA SCIENCES : HC Wainwright Adjusts Alimera Sciences PT to $12 From $16, Maintains Buy Rating
MT
ALIMERA SCIENCES : HC Wainwright Adjusts Alimera Sciences' Price Target to $16 From $14, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALIM Stock
  4. News Alimera Sciences, Inc.
  5. Analyst Reco.